Fitbit invests $6M into blood glucose monitoring startup

Fitbit invested $6 million into Sano, a startup developing a coin-sized patch that tracks blood glucose levels, Fitbit CEO James Park confirmed to CNBC.

The investment, which marks Fitbit's first-ever startup investment, is part of a financing round Sano plans to close in the coming months, according to CNBC. Sano's patch, which the company expects to release in roughly a year, is intended to help people with Type 1 and Type 2 diabetes control their blood glucose levels.

"This [investment] fits into our strategy of looking beyond the device and thinking more about [health] solutions," Mr. Park told CNBC. "I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment."

Mr. Park declined to comment on whether future Fitbit wearables would include built-in glucose tracking.

More articles on health IT:
Baptist Health South Florida taps health tech startup for precision cancer care
Kaiser CIO joins Parkland Center for Clinical Innovation's board of directors: 3 things to know
KLAS: 13 population health management vendors ranked by user satisfaction

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months